Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toll-like receptors 2, 3, 7, and 8 are single-pass transmembrane proteins expressed predominantly in immune cells. Each receptor detects different pathogen-associated molecular patterns: TLR2 recognizes bacterial lipoproteins; TLR3 recognizes double-stranded viral RNA; TLR7 and TLR8 recognize single-stranded viral RNA. Upon ligand binding, they initiate signal transduction through adaptor proteins (MyD88, TRIF), activating NF-κB and IRFs to produce inflammatory cytokines and type I interferons, thereby orchestrating the immune response. Their dysregulation is associated with infectious, inflammatory, and autoimmune diseases, making them important targets for drug development and disease modulation.
Agonism (immune stimulation by triggering receptors); Antagonism/inhibition (immune suppression or reduction of excess inflammation); Downstream signaling via MyD88-dependent and TRIF-dependent pathways, leading to NF-κB and interferon production
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toll-like receptors 2, 3, 7, and 8 (TLR2, TLR3, TLR7, TLR8).